Results 231 to 240 of about 108,288 (261)
Some of the next articles are maybe not open access.
NHL (diffuse large B-cell lymphoma).
BMJ clinical evidence, 2016Non-Hodgkin's lymphoma (NHL) is the sixth most common cancer in the UK; 9443 new cases were diagnosed in the UK in 2002, and it caused 4418 UK deaths in 2003. Incidence rates show distinct geographical variation, with age-standardised incidence rates ranging from 17 per 100,000 in northern America to 4 per 100,000 in south-central Asia. NHL occurs more
Fiona, Kyle, Mark, Hill
openaire +3 more sources
Diffuse large B-cell lymphoma in the older
Critical Reviews in Oncology/Hematology, 2011The incidence of diffuse large B-cell lymphoma (DLCL) in the older is growing to the point of becoming a health priority in the next decades. Prognostic factors and the biology of the tumor are not very different between younger and older populations.
A, Gutiérrez +3 more
openaire +2 more sources
Treatment of diffuse large B-cell lymphomas
memo - Magazine of European Medical Oncology, 2009Diffuse large B-cell lymphoma represent 40% of all lymphoma. The development of dose-dense chemotherapeutic regimens and the application of the monoclonal CD20 antibody rituximab improve the prognosis significantly. Evaluation of clinical risk factors (age, stage, LDH, ECOG performance status, number of extranodal involvement) at initial diagnosis are ...
B, Gleissner, C, Zwick, M, Pfreundschuh
openaire +2 more sources
The Management of an Orbital Diffuse Large B-Cell Lymphoma
Journal of Craniofacial Surgery, 2014The orbit represents a rare site of presentation of non-Hodgkin lymphoma. The diagnosis and management of orbital lymphomas may be challenging because these neoplasms present few specific features.A 69-year-old woman presented with painless swelling of the left lower eyelid of 5 years' duration.
De Stefani A. +2 more
openaire +4 more sources
Prognostic models for diffuse large b‐cell lymphoma
Hematological Oncology, 2000Prognosis of DLCL patients is variable and associated with well-defined risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an international consensus study, has been one of the most widely ...
A, Conconi +7 more
openaire +2 more sources
Pathogenesis of diffuse large B cell lymphoma
International Journal of Hematology, 2010Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormalities.
openaire +2 more sources
ALK‐positive diffuse large B‐cell lymphoma
Pediatric Blood & Cancer, 2005AbstractAnaplastic lymphoma kinase (ALK) positive diffuse large B‐cell lymphoma (DLBCL) is a rare subtype of non‐Hodgkins lymphoma. Five such cases have been described in children. We present a 9‐year‐old boy, in whom diagnosis of DLBCL has been established in addition to congenital multiple enchondromatosis. Immunohistopathological evaluation of tumor
Bubala, Halina +4 more
openaire +2 more sources
Pancreatic Diffuse Large B-Cell Lymphoma
Journal of Gastrointestinal Surgery, 2023Cuiping Zhang, Keping Tan, Jun Li
openaire +2 more sources
Diffuse large B-cell lymphoma of the testis
Blood, 2022Falini, Brunangelo, Lazzi, Stefano
openaire +3 more sources
Endobronchial Diffuse Large B-cell Lymphoma
Archivos de Bronconeumología (English Edition), 2020Masahiro, Yamasaki +2 more
openaire +2 more sources